J. Roth

发表

Induction of apoptosis and inhibition of tumorigenicity and tumor growth by adenovirus vector-mediated fragile histidine triad (FHIT) gene overexpression.

J. Minna, J. Roth, B. Fang, 1999, Cancer research.

An effective immunization and cancer treatment with activated dendritic cells transduced with full-length wild-type p53

J. Roth, S. Chada, B. Fang, 2002, Gene Therapy.

Cell cycle arrest and inhibition of tumor cell proliferation by the p16INK4 gene mediated by an adenovirus vector.

J. Roth, W. Zhang, A. Kyritsis, 1995, Cancer research.

Growth suppression of human head and neck cancer cells by the introduction of a wild-type p53 gene via a recombinant adenovirus.

J. Roth, T. Liu, G. Clayman, 1994, Cancer research.

Antitumor activity and bystander effects of the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) gene.

S. Curley, J. Gu, J. Roth, 2001, Cancer research.

A binary adenoviral vector system for expressing high levels of the proapoptotic gene bax

L Ji, J. Roth, S. Swisher, 2000, Gene Therapy.

Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression

J. Roth, W. Zhang, L. Owen-Schaub, 1995, Molecular and cellular biology.

Adenovirus-mediated Bax overexpression for the induction of therapeutic apoptosis in prostate cancer.

J. Roth, X. Li, B. Fang, 2001, Cancer research.

Adenovirus-mediated wild-type p53 gene transfer down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in human colon cancer.

L. Ellis, Wenbiao Liu, C. Bucana, 1998, Cancer research.

A retroviral wild-type p53 expression vector penetrates human lung cancer spheroids and inhibits growth by inducing apoptosis.

J. Roth, T. Fujiwara, T. Mukhopadhyay, 1993, Cancer research.

Augmenting transgene expression from carcinoembryonic antigen (CEA) promoter via a GAL4 gene regulatory system.

J. Gu, J. Roth, P. Koch, 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

Induction of chemosensitivity in human lung cancer cells in vivo by adenovirus-mediated transfer of the wild-type p53 gene.

J. Roth, T. Mukhopadhyay, W. Zhang, 1994, Cancer research.

Differential expression of the c-erbB-2 gene in human small cell and non-small cell lung cancer.

J. Roth, M. Hung, J. Manning, 1989, Cancer research.

Specific inhibition of K-ras expression and tumorigenicity of lung cancer cells by antisense RNA.

J. Roth, M. Tainsky, T. Mukhopadhyay, 1991, Cancer research.

Individual Participant Data Network Meta-Analysis of Neoadjuvant Chemotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal Junction Carcinoma

V. Gebski, J. Pignon, P. Schlag, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Molecular therapy for peritoneal dissemination of xenotransplanted human MKN-45 gastric cancer cells with adenovirus mediated Bax gene transfer

J. Roth, T. Fujiwara, T. Fujiwara, 2004, Gut.

A synthetic tris-sulfotyrosyl dodecapeptide analogue of the insulin receptor 1146-kinase domain inhibits tyrosine dephosphorylation of the insulin receptor in situ.

M. Bernier, H. Kole, A. Liotta, 1994, The Journal of biological chemistry.

Liposomal vector mediated delivery of the 3p FUS1 gene demonstrates potent antitumor activity against human lung cancer in vivo

J. Minna, J. Roth, R. Ramesh, 2004, Cancer Gene Therapy.

hTERT promoter induces tumor-specific Bax gene expression and cell killing in syngenic mouse tumor model and prevents systemic toxicity

B. Fang, J. Gu, J. Gu, 2002, Gene Therapy.

A pan-cancer PDX histology image repository with genomic and pathological annotations for deep learning analysis

Steven B. Neuhauser, Yvonne A. Evrard, Jeffrey H. Chuang, 2022, bioRxiv.

Delivery of the p53 tumor suppressor gene into lung cancer cells by an adenovirus/DNA complex.

J. Roth, C. Branch, D. Nguyen, 1997, Cancer gene therapy.

Stable expression of the wild-type p53 gene in human lung cancer cells after retrovirus-mediated gene transfer.

J. Roth, T. Fujiwara, T. Mukhopadhyay, 1993, Human gene therapy.

Combination effect of oncolytic adenovirotherapy and TRAIL gene therapy in syngeneic murine breast cancer models

J. Roth, H. Jiang, B. Fang, 2006, Cancer Gene Therapy.

Modulation of the proteostasis network promotes tumor resistance to oncogenic KRAS inhibitors

Sara R. Savage, Xi Chen, Eric Chang, 2023, Science.

Elevated NSD3 histone methylation activity drives squamous cell lung cancer

J. Minna, I. Wistuba, P. Mazur, 2021, Nature.

Characterization of GP120 binding to CD4 and an assay that measures ability of sera to inhibit this binding.

A. Fauci, H. Lane, S. Koenig, 1988, Journal of immunology.

A rapid and efficient method for purification of recombinant adenovirus with RGD-modified fibers

B. Fang, Li Wang, Shuhong Wu, 2008 .

Retroviral‐mediated transduction of p53 gene increases TGF‐β expression in a human glioblastoma cell line

T. Fujiwara, D. Morris, T. Mukhopadhyay, 1994 .

Deficiency of caspase-3 in MCF7 cells blocks Bax-mediated nuclear fragmentation but not cell death.

J. Gu, S. Swisher, T. McDonnell, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

Factors limiting adenovirus-mediated gene transfer into human lung and pancreatic cancer cell lines.

J. Roth, M. Xiong, P. Koch, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.